Stimcell Energetics (STME) EPS (Diluted) Growth (1y) (2017 - 2024)
Stimcell Energetics (STME) EPS (Diluted) Growth (1y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 13.96% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -57.41% |
| Feb 29, 2024 | 42.84% |
| Nov 30, 2023 | 57.60% |
| Aug 31, 2023 | 50.25% |
| May 31, 2023 | 51.17% |
| Feb 28, 2023 | 1.11% |
| Nov 30, 2022 | 18.85% |
| Aug 31, 2022 | 35.37% |
| May 31, 2022 | 13.36% |
| Feb 28, 2022 | 33.25% |
| Nov 30, 2021 | 7.06% |
| Aug 31, 2021 | -18.96% |
| May 31, 2021 | 25.49% |
| Feb 28, 2021 | 49.76% |
| Nov 30, 2020 | 37.61% |
| Aug 31, 2020 | 17.97% |
| May 31, 2020 | 78.90% |
| Feb 29, 2020 | -319.80% |
| Nov 30, 2019 | -348.31% |
| Aug 31, 2019 | -202.72% |